Clinical Trial Update: Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating long-term maintenance with TRIZIVIR after boosted PI or NNRTI in HIV-1 infected adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Trizivir

Snippet

Sponsor: GlaxoSmithKline | Conditions: HIV Infections | Phase 4 | Status: COMPLETED